Boundless Bio
(NASDAQ) BOLD
Boundless Bio Financials at a Glance
Market Cap
$31.45M
Revenue (TTM)
$0.00
Net Income (TTM)
-$55.99M
EPS (TTM)
-$2.50
P/E Ratio
-0.56
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Price
$1.42
Volume
141,116
Open
$1.43
Price
$1.42
Volume
141,116
Open
$1.43
Previous Close
$1.41
Daily Range
$1.40 - $1.44
52-Week Range
$0.96 - $1.68
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Price
$1.42
Volume
141,116
Open
$1.43
Previous Close
$1.41
Daily Range
$1.40 - $1.44
52-Week Range
$0.96 - $1.68
Estimated Earnings Date
Aug 4, 2026
BOLD News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Boundless Bio
Industry
Biotechnology
Sector
Health CareEmployees
28
CEO
Zachary D. Hornby, MBA
Website
www.boundlessbio.comHeadquarters
San Diego, CA 92121, US
BOLD Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-50%
Return on Capital
-46%
Return on Assets
-40%
Earnings Yield
-1.79%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$31.45M
Shares Outstanding
22.46M
Volume
141.12K
Avg. Volume
214.41K
Financials (TTM)
Gross Profit
-$1.25M
Operating Income
-$63.55M
EBITDA
-$56.95M
Operating Cash Flow
-$46.66M
Capital Expenditure
-$546.00K
Free Cash Flow
-$47.21M
Cash & ST Invst.
$107.58M
Total Debt
$49.04M
Boundless Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$284.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$31.45M
N/A
Market Cap/Employee
$491.40K
N/A
Employees
64
N/A
Net Income
-$13.56M
+14.0%
EBITDA
-$13.27M
+14.1%
Quarterly Fundamentals
Total Cash
$92.85M
-32.8%
Total Debt
$48.29M
-0.6%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$45.00M
-6.8%
Short Term Debt
$3.28M
+1153.4%
Return on Assets
-39.72%
N/A
Return on Invested Capital
-46.19%
N/A
Free Cash Flow
-$14.98M
-2.7%
Operating Cash Flow
-$14.97M
-3.0%